Box-plots indicating genes affected by treatment effect among CRML patients with no or mild SD only (oxaliplatin (n = 26) vs. oxaliplatin + bev (n = 22)).

Abstract

<p>Two-way ANOVA with treatment and SD status as factors was used. P-value and FDR < 0.05 are indicated in each box plot graph <b>(A-E)</b>. OX = oxaliplatin, Bev = bevacizumab.</p